maybe I should have explained what AVID is firstly:
The biennial AVID (Australian Vaccine and Immunotherapeutics Development) meetings are designed to bring together a wide range of scientists and clinicians from both Australia and overseas, to discuss novel biotherapies for the treatment of important human and animal diseases. The meeting will cover programs that are developing new vaccines, therapeutic antibodies and other novel biopharamaceutical treatments. AVID seeks to bring together these key groups along with academia and reprentantives from the business world to share in the latest developments in these areas and to discuss both their successes and failures.
The 2010 AVID meeting (the 3rd AVID meeting) will take place in Melbourne at the Bio21 facility from 5th to 7th May. The organising committee is in the process of inviting top local and international speakers to cover a wide range of products in development and undergoing clinical trial
- Forums
- ASX - By Stock
- commercial development of vaccines
maybe I should have explained what AVID is firstly:The biennial...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online